Prognostic Value of Plasma Heart-Type Fatty Acid-Binding Protein in Patients With Acute Pulmonary Embolism: A Meta-analysis

Chest

Volumn 146, Issue 6, 2014, Pages 1462-1467

  Ruan, Li Bo ^a   He, Liang ^b   Zhao, Shan ^a   Zhu, Ping ^c   Li, Wei Yuan ^a  

^a First Hospital of Yunnan Province   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; HYPERTENSIVE FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FABP3 PROTEIN, HUMAN;

ACUTE PULMONARY EMBOLISM; ARTICLE; BLOOD CLOT LYSIS; DISEASE SEVERITY; HUMAN; LONG TERM SURVIVAL; LUNG EMBOLISM; META ANALYSIS; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RESUSCITATION; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ACUTE DISEASE; BLOOD; FEMALE; MALE; PREDICTIVE VALUE; PULMONARY EMBOLISM; SEVERITY OF ILLNESS INDEX; SURVIVAL;

ACUTE DISEASE; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84924309552     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1008     Document Type: Article

References (16)

1. 1 Konstantinides, S, Goldhaber, SZ, Pulmonary embolism: risk assessment and management. Eur Heart J 33:24 (2012), 3014–3022.
2. 2 Torbicki, A, Perrier, A, Konstantinides, S, et al. ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29:18 (2008), 2276–2315.
3. 3 Lankeit, M, Friesen, D, Aschoff, J, et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J 31:15 (2010), 1836–1844.
4. 4 Vuilleumier, N, Le Gal, G, Verschuren, F, et al. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study. J Thromb Haemost 7:3 (2009), 391–398.
5. 5 Becattini, C, Vedovati, MC, Agnelli, G, Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 116:4 (2007), 427–433.
6. 6 Cavallazzi, R, Nair, A, Vasu, T, Marik, PE, Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med 34:12 (2008), 2147–2156.
7. 7 Kostrubiec, M, Pruszczyk, P, Bochowicz, A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 26:20 (2005), 2166–2172.
8. 8 Boscheri, A, Wunderlich, C, Langer, M, et al. Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am Heart J 160:2 (2010), 294–300.
9. 9 Kaczyñska, A, Pelsers, MM, Bochowicz, A, Kostrubiec, M, Glatz, JF, Pruszczyk, P, Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 371:1-2 (2006), 117–123.
10. 10 Puls, M, Dellas, C, Lankeit, M, et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J 28:2 (2007), 224–229.
11. 11 Dellas, C, Puls, M, Lankeit, M, et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol 55:19 (2010), 2150–2157.
12. 12 Gül, EE, Can, I, Güler, I, et al. Association of pulmonary artery obstruction index with elevated heart-type fatty acid binding protein and short-term mortality in patients with pulmonary embolism at intermediate risk. Diagn Interv Radiol 18:6 (2012), 531–536.
13. 13 Alhadi, HA, Fox, KA, Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM 97:4 (2004), 187–198.
14. 14 Storch, J, Thumser, AE, The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486:1 (2000), 28–44.
15. 15 Lankeit, M, Dellas, C, Panzenböck, A, et al. Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur Respir J 31:5 (2008), 1024–1029.
16. 16 Dellas, C, Tschepe, M, Seeber, V, et al. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost 111:5 (2014), 996–1003.